NCT00488020

Stem Cells for Treating Critical Ischemia

the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: Instituto de Molestias Cardiovasculares · Academic / Other
• Sex: All
• Age: 30 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Collection of bone marrow blood Selection of mononuclear cells dilution with albumin injection into the calf muscles through 40 shots

Detailed description

About 500cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly 4 hours.After dilution in albumin (40cc)the mononuclear cells are injected into the calf muscles through 40 shots.This procedure is indicated for patients with lower limb ischemia on whom all the others known therapies have failed

Conditions

• Critical Limb Ischemia
• Ischemic Ulcers

Interventions

Type	Name	Description
PROCEDURE	stem cells transplant

Timeline

• Start date: 2006-04-01
• Completion: 2007-06-01
• First posted: 2007-06-19
• Last updated: 2008-06-13

Locations

1 site across 1 country: Brazil